dihexa pnb-0408 c-met hgfr activator HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment dihexa chemical properties solubility stability
dihexa chemical properties solubility stability Cabozantinib hydrochloride c Met inhibitor CAS 1817759 42 4 Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion PMC Nrf2 Independent Anti Inflammatory Effects of Dimethyl Fumarate: Challenges and Prospects in Developing Electrophilic Nrf2 Activators for Neurodegenerative Diseases MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology
Pay in 4 interest-free payments of $5.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24



